ISSA: novel functional approach to cancer-related genes
ISSA: novel functional approach to cancer-related genes
批准号:
7059376
负责人:
ANDREI V GUDKOV
金额:
$14.94万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2007-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Identification of genes and pathways that contribute to tumorigenesis should lead to the defining of novel targets for therapeutic intervention and provide biomarkers for better diagnosis, staging, and risk assessment for individual cancer patients. Further progress in molecular genetics of cancer would greatly benefit from a reliable methodology of assigning gene functions based on phenotypic changes resulting from modulations in gene expression. Existing techniques of this kind are based on screening of genetically modified cells for genetic elements favoring cell growth under restrictive conditions (positive selection). Recently, a novel gene discovery methodology, named selection subtraction approach (SSA), was developed that allowed for a direct negative selection. Although proven useful for isolation of killing or growth suppressive genetic elements, SSA's capabilities are limited by the necessity to construct expression libraries. This proposal is focused on developing a new Insertional Selection Subtraction Approach (ISSA) that combines the advantages of SSA with the power of retroviral insertional mutagenesis and is based on a completely new vector system. The insertional mutagenesis arm is enhanced by the addition of a regulatable promoter, splice donor sequences, and the ability to trap polyadenylation signals. The second arm of ISSA involves "tagging" or "bar-coding" each mutant (SSA), thereby allowing to monitor the relative abundance of mutants within the population during selection by using "retrophage arrays," the key component of SSA. ISSA technique promises to become a universal functional screening tool, free from major drawbacks of its precursors. After "technical" testing of ISSA, its power will be determined by identification of genes involved in regulation of cell sensitivity to TNF, a well-characterized system that has been already well studied by numerous approaches, including functional selection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
"Combining radiation with TLR5 agonist based immunotherapy against liver metastases"
-
批准号:9806462
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2019
-
负责人:ANDREI V GUDKOV
-
依托单位:
Mechanisms of mitigation of radiation damage of GI tract by Protectan CBLB502
-
批准号:7938617
-
项目类别:
-
资助金额:$248.52万
-
财政年份:2009
-
负责人:ANDREI V GUDKOV
-
依托单位:
Mechanisms of mitigation of radiation damage of GI tract by Protectan CBLB502
-
批准号:7865476
-
项目类别:
-
资助金额:$284.44万
-
财政年份:2009
-
负责人:ANDREI V GUDKOV
-
依托单位:
Protectan CBLB502
-
批准号:7919056
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2009
-
负责人:ANDREI V GUDKOV
-
依托单位:
Controlling Radiation Injury by TLR5 Agonists
-
批准号:7557556
-
项目类别:
-
资助金额:$33.84万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
Controlling Radiation Injury by TLR5 Agonists
-
批准号:8103080
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
Controlling Radiation Injury by TLR5 Agonists
-
批准号:7661631
-
项目类别:
-
资助金额:$34.26万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
Protectan CBLB502
-
批准号:7555568
-
项目类别:
-
资助金额:$77.42万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
Controlling Radiation Injury by TLR5 Agonists
-
批准号:8303363
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
Controlling Radiation Injury by TLR5 Agonists
-
批准号:7897773
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2008
-
负责人:ANDREI V GUDKOV
-
依托单位:
ISSA: novel functional approach to cancer-related genes
-
批准号:6873830
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2005
-
负责人:ANDREI V GUDKOV
-
依托单位:
Protecting immune system by modulators of p53 and NF-kB
-
批准号:6998623
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2005
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:6901131
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:7233212
-
项目类别:
-
资助金额:$2.77万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:7064286
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:6759439
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:6630983
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
Diagnostic Therapeutic Targets in Prostate Cancer
-
批准号:7493173
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2003
-
负责人:ANDREI V GUDKOV
-
依托单位:
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT
-
批准号:6194291
-
项目类别:
-
资助金额:$29.44万
-
财政年份:2000
-
负责人:ANDREI V GUDKOV
-
依托单位:
STRESS INDUCED BYSTANDER EFFECT IN CANCER TREATMENT
-
批准号:6514735
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:ANDREI V GUDKOV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: